Mark Nilson is a scientific leader in drug substance development with a background in natural products synthesis. They completed a graduate program at Penn State University from 2005 to 2011 and pursued post-doctoral research at the University of Pennsylvania from 2012 to 2013. Mark held the position of scientific leader at GSK and served as an investigator and principal investigator within the organization.
This person is not in the org chart
This person is not in any teams
This person is not in any offices